Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2008

01-09-2008 | Original Article

Sodium Intake and Mortality Follow-Up in the Third National Health and Nutrition Examination Survey (NHANES III)

Authors: Hillel W. Cohen, DrPH, MPH, Susan M. Hailpern, MS, DrPH, Michael H. Alderman, MD

Published in: Journal of General Internal Medicine | Issue 9/2008

Login to get access

Abstract

Background

Sodium restriction is commonly recommended as a measure to lower blood pressure and thus reduce cardiovascular disease (CVD) and all-cause mortality. However, some studies have observed higher mortality associated with lower sodium intake.

Objective

To test the hypothesis that lower sodium is associated with subsequent higher cardiovascular disease (CVD) and all cause mortality in the Third National Health and Nutrition Examination Survey (NHANES III).

Design

Observational cohort study of mortality subsequent to a baseline survey.

Participants

Representative sample (n = 8,699) of non-institutionalized US adults age ≥30, without history of CVD events, recruited between 1988–1994.

Measurements and main results

Dietary sodium and calorie intakes estimated from a single baseline 24-h dietary recall. Vital status and cause of death were obtained from the National Death Index through the year 2000. Hazard ratio (HR) for CVD mortality of lowest to highest quartile of sodium, adjusted for calories and other CVD risk factors, in a Cox model, was 1.80 (95% CI 1.05, 3.08, p = 0.03). Non-significant trends of an inverse association of continuous sodium (per 1,000 mg) intake with CVD and all-cause mortality were observed with a 99% CI of 0.73, 1.06 (p = 0.07) and 0.86, 1.04 (p = 0.11), respectively, while trends for a direct association were not observed.

Conclusion

Observed associations of lower sodium with higher mortality were modest and mostly not statistically significant. However, these findings also suggest that for the general US adult population, higher sodium is unlikely to be independently associated with higher CVD or all-cause mortality.
Literature
2.
go back to reference Joint National Committee for the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee for the prevention, detection, evaluation, and treatment of high blood pressure (JNC VII). JAMA. 2003;289:2560–72.CrossRef Joint National Committee for the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee for the prevention, detection, evaluation, and treatment of high blood pressure (JNC VII). JAMA. 2003;289:2560–72.CrossRef
3.
go back to reference Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002;106(33):88–91.PubMedCrossRef Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002;106(33):88–91.PubMedCrossRef
4.
go back to reference Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003656. DOI 10.1002/14651858.CD003656.pub2. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003656. DOI 10.​1002/​14651858.​CD003656.​pub2.
5.
go back to reference Tunstall-Pedoe H, Woodward M, Tavendale R, A’Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ. 1997;315:722–9.PubMed Tunstall-Pedoe H, Woodward M, Tavendale R, A’Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ. 1997;315:722–9.PubMed
6.
go back to reference He J, Ogden LG, Vupputuri S, Bassano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–34.PubMedCrossRef He J, Ogden LG, Vupputuri S, Bassano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–34.PubMedCrossRef
7.
go back to reference Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;347:848–51.CrossRef Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;347:848–51.CrossRef
8.
go back to reference Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke. 2004;15:1543–7.CrossRef Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke. 2004;15:1543–7.CrossRef
9.
go back to reference Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of trials of hypertension prevention (TOHP). BMJ 2007 DOI 10.1136/bmj.39147.604896.55. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of trials of hypertension prevention (TOHP). BMJ 2007 DOI 10.​1136/​bmj.​39147.​604896.​55.
10.
go back to reference Kagen A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985;16:390–6. Kagen A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985;16:390–6.
11.
go back to reference Cohen JD, Grandis G, Cutler JA, Neaton JD, Juller LH, Stamler J. Dietary sodium intake and mortality: MRFIT Follow-up Study Results (abstract). Circulation. 1999;100(suppl 1):1–524. Cohen JD, Grandis G, Cutler JA, Neaton JD, Juller LH, Stamler J. Dietary sodium intake and mortality: MRFIT Follow-up Study Results (abstract). Circulation. 1999;100(suppl 1):1–524.
12.
go back to reference Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–52.PubMed Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–52.PubMed
13.
go back to reference Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Survey (NHANES I)>. Lancet. 1998;351:781–5.PubMedCrossRef Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Survey (NHANES I)>. Lancet. 1998;351:781–5.PubMedCrossRef
14.
go back to reference Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II Follow-up Study. Am J Med. 2006;119:274e7–5e14. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II Follow-up Study. Am J Med. 2006;119:274e7–5e14.
15.
go back to reference Cohen HW, Alderman MH. Sodium, blood pressure, and cardiovascular disease. Curr Opin Cardiol. 2007;22:306–10.PubMedCrossRef Cohen HW, Alderman MH. Sodium, blood pressure, and cardiovascular disease. Curr Opin Cardiol. 2007;22:306–10.PubMedCrossRef
19.
go back to reference National Center for Health Statistics. International Classification of Diseases, Ninth Revision (ICD-9). Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/ NCHS/Publications/ICD-9. Last accessed April 16, 2008. National Center for Health Statistics. International Classification of Diseases, Ninth Revision (ICD-9). Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/ NCHS/Publications/ICD-9. Last accessed April 16, 2008.
21.
go back to reference Willett W, Stampfer MF. Total energy intake: implications for epidemiologic analyses. Am J Epidemiology. 1986;124:17–27. Willett W, Stampfer MF. Total energy intake: implications for epidemiologic analyses. Am J Epidemiology. 1986;124:17–27.
22.
go back to reference Willett W. Nutritional Epidemiology. 2nd ed. Oxford, England: Oxford University Press; 1998. Willett W. Nutritional Epidemiology. 2nd ed. Oxford, England: Oxford University Press; 1998.
23.
go back to reference Alderman MH. Presidential address: 21st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the ‘J’-shaped relation. J Hypertens. 2007;25(5):903–7.PubMedCrossRef Alderman MH. Presidential address: 21st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the ‘J’-shaped relation. J Hypertens. 2007;25(5):903–7.PubMedCrossRef
Metadata
Title
Sodium Intake and Mortality Follow-Up in the Third National Health and Nutrition Examination Survey (NHANES III)
Authors
Hillel W. Cohen, DrPH, MPH
Susan M. Hailpern, MS, DrPH
Michael H. Alderman, MD
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0645-6

Other articles of this Issue 9/2008

Journal of General Internal Medicine 9/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.